Quinolinylpiperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain

Details for Australian Patent Application No. 2001244982 (hide)

Owner AstraZeneca AB

Inventors Walpole, Christopher; Brown, William; Wei, Zhongyong

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2001244982

PCT Pub. Number WO01/74806

Priority 0001208 04.04.00 SE

Filing date 30 March 2001

Wipo publication date 15 October 2001

Acceptance publication date 24 November 2005

International Classifications

C07D 401/14 Heterocyclic compounds containing two or more hetero rings

A61K 031/4523 - containing further heterocyclic ring systems

C07D 409/14 Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

A61P 025/04 Drugs for disorders of the nervous system

C07D 405/14 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 211/68 Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61P 025/00 Drugs for disorders of the nervous system

Event Publications

24 November 2005 Application Accepted

  Published as AU-B-2001244982

23 March 2006 Standard Patent Sealed

29 October 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001244983

2001244981